These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8865848

  • 1. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.
    Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E.
    Virchows Arch; 1996 Sep; 429(1):13-9. PubMed ID: 8865848
    [Abstract] [Full Text] [Related]

  • 2. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
    Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E.
    J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
    [Abstract] [Full Text] [Related]

  • 3. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.
    Yasui W, Kudo Y, Naka K, Fujimoto J, Ue T, Yokozaki H, Tahara E.
    Int J Oncol; 1998 Jun; 12(6):1253-8. PubMed ID: 9592182
    [Abstract] [Full Text] [Related]

  • 4. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
    Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E.
    J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
    [Abstract] [Full Text] [Related]

  • 5. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.
    Yasui W, Akama Y, Yokozaki H, Semba S, Kudo Y, Shimamoto F, Tahara E.
    Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386
    [Abstract] [Full Text] [Related]

  • 6. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
    Zheng J, Zhu Y, Li C, Li Y, Nie Q, Zhu Z, Deng H.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(4):335-341. PubMed ID: 27868405
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE, Goussia AC, Machera M, Tsianos EV, Kappas AM, Agnantis NJ.
    Anticancer Res; 1999 May 25; 19(3A):2147-55. PubMed ID: 10470163
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of p53 protein and proliferative activity in colorectal adenoma.
    Yamaguchi A, Makimoto K, Goi T, Takeuchi K, Maehara M, Isobe Y, Nakagawara G.
    Oncology; 1994 May 25; 51(3):224-7. PubMed ID: 7910956
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC, Ginn PE, Homer B, Fox LE, Kurzman ID.
    Vet Pathol; 1997 Sep 25; 34(5):394-404. PubMed ID: 9381650
    [Abstract] [Full Text] [Related]

  • 11. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
    Kim YS, Lim SD, Lee JK, Kim SE, Ryu SH, Lee JW, Moon JS.
    Korean J Gastroenterol; 2006 May 25; 47(5):350-6. PubMed ID: 16714876
    [Abstract] [Full Text] [Related]

  • 12. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV, Săftoiu A, Georgescu CC, Ciurea R, Ciurea T.
    J Gastrointestin Liver Dis; 2007 Jun 25; 16(2):133-9. PubMed ID: 17592558
    [Abstract] [Full Text] [Related]

  • 13. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K, Watanabe H, Itoi T, Saito T.
    Pathol Int; 1996 Jun 25; 46(6):426-35. PubMed ID: 8869994
    [Abstract] [Full Text] [Related]

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ.
    Urol Int; 2004 Jun 25; 73(1):65-73. PubMed ID: 15263796
    [Abstract] [Full Text] [Related]

  • 15. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K, Watanabe H, Itoi T, Saito T.
    Pathol Int; 1996 Nov 25; 46(11):908-17. PubMed ID: 8970203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expressions of cell-cycle regulatory gene products in conventional gastric adenomas: possible immunohistochemical markers of malignant transformation.
    Oya M, Yao T, Tsuneyoshi M.
    Hum Pathol; 2000 Mar 25; 31(3):279-87. PubMed ID: 10746668
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas.
    Sugai T, Nakamura SI, Habano W, Uesugi N, Sato H, Yoshida T, Orii S.
    Pathol Int; 1999 Jul 25; 49(7):617-25. PubMed ID: 10504522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apoptosis and its regulation in flat-type early colorectal carcinoma: comparison with that in polypoid-type early colorectal carcinoma.
    Ozawa A, Konishi F, Fukayama M, Kanazawa K.
    Dis Colon Rectum; 2000 Oct 25; 43(10 Suppl):S23-8. PubMed ID: 11052474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.